These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9200443)

  • 1. Regulation of tumor antigen presentation by urocanic acid.
    Beissert S; Mohammad T; Torri H; Lonati A; Yan Z; Morrison H; Granstein RD
    J Immunol; 1997 Jul; 159(1):92-6. PubMed ID: 9200443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Beissert S; Hosoi J; Grabbe S; Asahina A; Granstein RD
    J Immunol; 1995 Feb; 154(3):1280-6. PubMed ID: 7822797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal cell presentation of tumor-associated antigens for induction of tolerance.
    Tan KC; Hosoi J; Grabbe S; Asahina A; Granstein RD
    J Immunol; 1994 Jul; 153(2):760-7. PubMed ID: 7912706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesis.
    Beissert S; Rühlemann D; Mohammad T; Grabbe S; El-Ghorr A; Norval M; Morrison H; Granstein RD; Schwarz T
    J Immunol; 2001 Dec; 167(11):6232-8. PubMed ID: 11714785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide.
    Asahina A; Hosoi J; Beissert S; Stratigos A; Granstein RD
    J Immunol; 1995 Apr; 154(7):3056-61. PubMed ID: 7897198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation.
    Moodycliffe AM; Bucana CD; Kripke ML; Norval M; Ullrich SE
    J Immunol; 1996 Oct; 157(7):2891-9. PubMed ID: 8816394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha.
    Kurimoto I; Streilein JW
    J Immunol; 1992 May; 148(10):3072-8. PubMed ID: 1578133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor antigen presentation by murine epidermal cells.
    Grabbe S; Bruvers S; Gallo RL; Knisely TL; Nazareno R; Granstein RD
    J Immunol; 1991 May; 146(10):3656-61. PubMed ID: 2026885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content.
    Beissert S; Ullrich SE; Hosoi J; Granstein RD
    J Leukoc Biol; 1995 Aug; 58(2):234-40. PubMed ID: 7643016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous humor inhibits epidermal cell antigen-presenting function.
    Hosoi J; Grabbe S; Knisely TL; Granstein RD
    Reg Immunol; 1993; 5(5):279-84. PubMed ID: 8148237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a monoclonal antibody to cis-urocanic acid: detection of cis-urocanic acid in the serum of irradiated mice by immunoassay.
    Moodycliffe AM; Norval M; Kimber I; Simpson TJ
    Immunology; 1993 Aug; 79(4):667-72. PubMed ID: 8406594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The degradation of L-histidine and trans- and cis-urocanic acid by bacteria from skin and the role of bacterial cis-urocanic acid isomerase.
    Hug DH; Dunkerson DD; Hunter JK
    J Photochem Photobiol B; 1999 May; 50(1):66-73. PubMed ID: 10443033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocanic acid enhances IL-10 production in activated CD4+ T cells.
    Holán V; Kuffová L; Zajícová A; Krulová M; Filipec M; Holler P; Jancárek A
    J Immunol; 1998 Oct; 161(7):3237-41. PubMed ID: 9759837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urocanic acid and cutaneous antigen presentation.
    Lappin MB; Simon JC
    J Photochem Photobiol B; 1998 Jul; 44(2):112-6. PubMed ID: 9757592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Grabbe S; Bruvers S; Granstein RD
    J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of histamine receptor antagonists on immunosuppression induced by the cis-isomer of urocanic acid.
    Norval M; Gilmour JW; Simpson TJ
    Photodermatol Photoimmunol Photomed; 1990 Dec; 7(6):243-8. PubMed ID: 1983293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleterious effects of cis-urocanic acid and UVB radiation on Langerhans cells and on induction of contact hypersensitivity are mediated by tumor necrosis factor-alpha.
    Kurimoto I; Streilein JW
    J Invest Dermatol; 1992 Nov; 99(5):69S-70S. PubMed ID: 1431236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for dermal mast cells in cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses in mice.
    Hart PH; Grimbaldeston MA; Swift GJ; Hosszu EK; Finlay-Jones JJ
    Photochem Photobiol; 1999 Nov; 70(5):807-12. PubMed ID: 10568173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of contact hypersensitivity by short-term ultraviolet irradiation: II. The role of urocanic acid.
    Harriott-Smith TG; Halliday WJ
    Clin Exp Immunol; 1988 Apr; 72(1):174-7. PubMed ID: 3396218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecific inhibition of human epidermal cell interleukin-1 secretion and HLA-DR expression by cis-urocanic acid.
    Räsänen L; Jansén CT; Reunala T; Morrison H
    Photodermatol; 1987 Aug; 4(4):182-6. PubMed ID: 3501579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.